Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER+ Invasive Breast Cancer (STAKT) (vol 26, pg 1574, 2020)John F. R. Robertson,Robert E. Coleman,Kwok-Leung Cheung,Abigail Evans,Chris Holcombe,Anthony Skene,Daniel Rea,Samreen Ahmed,Ali Jahan,Kieran Horgan,Petra Rauchhaus,Roberta Littleford,S. Y. Amy Cheung,Marie Cullberg,Elza C. de Bruin, Loumpiana Koulai,Justin P. O. Lindemann,Martin Pass, Paul Rugman,Gaia Schiavon,Rahul Deb,Pauline Finlay,Andrew Foxley,Julia M. W. GeeCLINICAL CANCER RESEARCH（2022）引用 0|浏览11暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
